A systematic literature review of attitudes towards secondary use and sharing of health administrative and clinical trial data: a focus on consent

E Hutchings, M Loomes, P Butow, FM Boyle - Systematic Reviews, 2021 - Springer
Background We aimed to synthesise data on issues related to stakeholder perceptions of
consent for the use of secondary data. To better understand the current literature available …

Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource

B Goldacre, NJ DeVito, C Heneghan, F Irving, S Bacon… - bmj, 2018 - bmj.com
Objectives To ascertain compliance rates with the European Commission's requirement that
all trials on the EU Clinical Trials Register (EUCTR) post results to the registry within 12 …

A systematic literature review of researchers' and healthcare professionals' attitudes towards the secondary use and sharing of health administrative and clinical trial …

E Hutchings, M Loomes, P Butow, FM Boyle - Systematic Reviews, 2020 - Springer
A systematic literature review of researchers and healthcare professionals' attitudes towards
the secondary use and sharing of health administrative and clinical trial data was conducted …

Sharing and reuse of individual participant data from clinical trials: principles and recommendations

C Ohmann, R Banzi, S Canham, S Battaglia, M Matei… - BMJ open, 2017 - bmjopen.bmj.com
Objectives We examined major issues associated with sharing of individual clinical trial data
and developed a consensus document on providing access to individual participant data …

Enhancing the usability of systematic reviews by improving the consideration and description of interventions

TC Hoffmann, AD Oxman, JPA Ioannidis, D Moher… - Bmj, 2017 - bmj.com
The importance of adequate intervention descriptions in minimising research waste and
improving research usability and reproducibility has gained attention in the past few years …

The promise and perils of industry‐funded science

B Holman, KC Elliott - Philosophy Compass, 2018 - Wiley Online Library
Private companies provide by far the most funding for scientific research and development.
Nevertheless, relatively little attention has been paid to the dynamics of industry‐funded …

[HTML][HTML] A knowledge base of clinical trial eligibility criteria

H Liu, Y Chi, A Butler, Y Sun, C Weng - Journal of biomedical informatics, 2021 - Elsevier
Abstract Objective We present the Clinical Trial Knowledge Base, a regularly updated
knowledge base of discrete clinical trial eligibility criteria equipped with a web-based user …

A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one

N Venugopal, G Saberwal - PLoS One, 2021 - journals.plos.org
Background It is an ethical and scientific obligation to register each clinical trial, and report
its results, accurately, comprehensively and on time. The WHO recognizes 17 public …

[HTML][HTML] The TrialsTracker: automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions

A Powell-Smith, B Goldacre - F1000Research, 2016 - ncbi.nlm.nih.gov
Background: Failure to publish trial results is a prevalent ethical breach with a negative
impact on patient care. Audit is an important tool for quality improvement. We set out to …

Jointly predicting job performance, personality, cognitive ability, affect, and well-being

P Robles-Granda, S Lin, X Wu… - IEEE Computational …, 2021 - ieeexplore.ieee.org
Assessment of individuals' job performance, personalized health and psychometric
measures are domains where data-driven ubiquitous computing will have a profound impact …